Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment

Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment

The prostaglandin D2 (PGD2) receptor, CRTH2, plays a role in allergic airway inflammation. The efficacy of BI 671800, a CRTH2 antagonist, was assessed in 2 separate trials in patients with asthma, in either the absence or the presence of inhaled corticosteroid (ICS) therapy. In this study, BI 671800...

Full description

Bibliographic Details
Main Authors: Hall, Ian P., Fowler, Andrew V., Gupta, Abhya, Tetzlaff, Kay, Nivens, Michael C., Sarno, Maria, Finnigan, Helen A., Bateman, Eric D., Rand Sutherland, E.
Format: Article
Published: Elsevier 2015
Online Access:https://eprints.nottingham.ac.uk/44366/

Internet

https://eprints.nottingham.ac.uk/44366/

Similar Items